PRC1, TNS4, and CDKN3, which were used to construct the model, had significantly higher mRNA expression in lung adenocarcinoma samples than normal samples in the TCGA cohort (Figure 3B). This evidence concerns the gene CDKN3 and lung adenocarcinoma.